Zyprexa (olanzapine) is now approved in Canada to treat bipolar MANIA

April 2003

Zyprexa (olanzapine) is now approved in Canada to treat bipolar MANIA.

Patients with mania have disruptive mood swings... euphoria, irritability, exhaustion, etc.

Episodes typically last at least a week.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

which drug to use for the initial treatment of hypertension
Diabetes Avandamet, the first combo tablet containing rosiglitazone plus metformin
caffeine might reduce the efficacy of methotrexate for rheumatoid arthritis
Cardiology rumour that enteric-coated ASA doesn't work for preventing cardiovascular disease
Cardiology new ACE inhibitor, Mavik (trandolapril) by Abbott
Dermatology latest treatments for rosacea
Women's Health Today Sponge is finally back
Renal & Urology alpha-blockers for urinary problems in WOMEN
HIV drug, Fuzeon (enfuvirtide), approved in the U.S
Pharmascience will discontinue several barbiturates
Zyprexa (olanzapine) is now approved in Canada to treat bipolar MANIA
Natural Medicines anti-aging supplements that appear to contain growth hormone
Obesity & Weight Loss Meridia (sibutramine) for obesity is safe
Gastroenterology A new formulation of Kaopectate in the U.S. is creating lots of confusion
Pneumonia theories on how the deadly pneumonia known as SARS is being transmitted